• Neurosciences

    Mayo Clinic Minute: Better-tolerated treatments for migraine pain

an African-American woman holding her head in her hands looking tired, worried or maybe with a headache or migraine

Migraine is a genetic neurologic disease that often goes diagnosed and undertreated. It's more than a typical headache. Sometimes migraine headaches come with pain so intense they can interrupt day-to-day activities.

The good news says Dr. Amaal Starling, a Mayo Clinic neurologist, is newer migraine headache treatment options are available that are more effective and better tolerated.

Watch: The Mayo Clinic Minute

Journalists: Broadcast-quality video (1:00) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script.

"Migraine is abnormal function in the brain. And this abnormal function results in abnormal sensory processing," says Dr. Starling.

And the most common sensation processed is pain. That's why prevention is ideal. One option is a family of drugs called calcitonin gene-related peptide, or CGRP, monoclonal antibodies.

"We're using that technology to create antibodies designed to target one specific protein," Dr. Starling says. "They're highly specific. It's basically like putting a treatment in a car and giving it a GPS to go directly to one part, in this case, the nervous system and reduce that activity of that protein."

Another treatment option is stimulating the vagus nerve.

"There is a noninvasive vagus nerve stimulation device that we use for the treatment of migraine to try to reduce the frequency as well as severity of attacks when they do occur," she says.

If prior treatments didn't work, it may be time to try again.

"It's important to re-engage with your healthcare professionals because we have so many more options that are available now that are better tolerated," says Dr. Starling.

Related posts:

For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.